Moderna has withdrawn its pending application for a combination vaccine for both the flu and Covid-19, saying it will resubmit later this year once it has more data.

One thing we know about viruses is that they are bound to evolve and SARS-CoV-2, the virus that causes COVID-19, is no exception. Since the beginning of the pandemic, we have seen a number of its ...

German biopharma company BioNTech has said it will commit up to £1 billion ($1.34 billion) in investment in the UK over the ...

Moderna said on Wednesday it had withdrawn the pending application for its flu and COVID combination vaccine candidate for ...

The FDA will make it more costly to seek approval of Covid-19 vaccines, but Moderna's shareholder reacted favorable to the ...

Moderna, Inc. (Nasdaq:MRNA), today announced that in consultation with the U.S. Food and Drug Administration (FDA), the ...

US regulators will no longer approve Covid booster shots for healthy adults and children without new studies, adding a costly ...

We recently published a list of These 10 Firms Just Beat the Market Today. In this article, we are going to take a look at ...

In this article, we named the 10 best-performing stocks during the trading session and detailed the reasons behind their gains.

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit ...

Moderna, Inc. (NASDAQ:MRNA) shares soared to the top of the S&P 500 gainers in early afternoon trading on May 20, surging by ...

The VRBPAC meeting comes the week after the World Health Organization (WHO) recommended that members consider using ...